Polymedco

Get ready for an exclusive behind-the-scenes look at Rewriting Cancer 🤍   With just one week until the series launch, we’re thrilled to unveil this powerful series that captures the highs and lows of lives affected by cancer. It showcases the incredible efforts in diagnosis, treatment, and care.   At Polymedco, we’re proud to have contributed a film to this impactful series, underscoring our commitment to early colon cancer detection and driving meaningful change in CRC identification.

Colon Cancer Screening Saves Lives 🌟   Polymedco is excited to announce its participation in the groundbreaking series "Rewriting Cancer" 📝. This initiative is a beacon of hope, symbolizing a global commitment to change the narrative around cancer. Mark your calendars for September 17th 🗓️, as we join forces with the Union for International Cancer Control (UICC) to share inspiring stories of innovation, resilience, and progress in the fight against cancer. Stay tuned as we, together with individuals and communities worldwide, are #RewritingCancer 🎗️. Don't miss out on our story of dedication and breakthroughs in early detection and screening that can save lives. 🩺💙

With the end of summer, we are getting back to our regular routines. Just like getting your flu shot, make annual screening for colon cancer part of your healthcare to do list. The American Cancer Society published that colon cancer is the leading cause of death in men under 50 and the second-leading in women, but ~90% of these deaths are preventable if detected early.1,2 If you are 45 years of age or older and at average risk for colon cancer**, you should be getting screened every year with FIT, a noninvasive stool test that can be completed from the comfort and privacy of home. For your annual screening, ask your healthcare professional about OC-Auto FIT® or visit https://hubs.la/Q02NRZ5l0 to learn more or get a screening test 1.Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024; 74(1): 12-49. doi:10.3322/caac.21820 2 Tepus M, Yau TO. Non-invasive colorectal cancer screening: an overview. Gastrointest Tumors. 2020;7(3):62-73. doi:10.1159/000507702 ** For screening purposes, you are at average risk of colorectal cancer if you do not have a personal history of colorectal cancer or certain types of polyps; a family history of colorectal cancer; a confirmed or suspected hereditary colorectal cancer syndrome, such as familial adenomatous polyposis (FAP) or Lynch syndrome (hereditary nonpolyposis colon cancer or HNPCC); a personal history of inflammatory bowel disease (ulcerative colitis or Crohn’s disease); or a personal history of abdominal or pelvic radiation for a previous cancer.

Thank you to everyone who joined us to celebrate, honor, and remember those affected by colon cancer at the Colon Cancer Coalition's Chicago Get Your Rear in Gear 5K Run/Walk. Polymedco is proud to be part of the fight to end colon cancer and save more lives through early detection. Find other events near you here: https://bit.ly/3AQsjvV Visit https://bit.ly/4dO51pc to learn more about screening with OC-Auto® FIT.

We are grateful to everyone who attended Dr Christenson’s Industry Workshop presentation on point-of-care hs-cTn at the 2024 ADLM meeting. We can’t wait to see you next year! Learn more about PATHFAST hs-cTnI-II from Polymedco, the first and only hs-cTn assay cleared by the FDA for point-of-care use, by visiting https://bit.ly/3Mdtd8c

Are you ready to Get Your Rear in Gear? Polymedco is proud to sponsor this year’s Chicago, IL Get Your Rear in Gear 5K Run/Walk to support the fight to end colon cancer with the @coloncancercoalition. Come join us on August 3rd at Montrose Harbor 601 W. Montrose Drive, to celebrate, honor, and remember those affected by colon cancer, and to learn about the importance of early detection. Learn more about the event, sign up, or donate here: https://bit.ly/3WjtBGJ

Attending ADLM? You will not want to miss Dr Robert H Christenson’s highly anticipated industry workshop presentation on point-of-care high-sensitivity cardiac troponin testing. Come see Dr Christenson present “Cardiac troponin I POC testing in the emergency department: What evidence, what applications, what algorithms, what timing and what technology?” • Wednesday, July 31, 2024 at 3:30–4:30 PM CT • Exhibit Hall Theater #1 This must-see industry workshop will highlight how POC high-sensitivity cardiac troponin (cTn) testing can improve patient and caregiver satisfaction, save system resources, and add value to laboratory medicine services.

Polymedco is pleased to offer OC-Auto® FIT for colorectal cancer (CRC) screening, the only automated noninvasive CRC screening tool with a proven impact on patient mortality.2 Visit Polymedco in booth 1742 at ADLM 2024 to learn more about our clinically proven CRC screening solutions or visit https://lnkd.in/d9F_u8Wm for more details. 1. Data on file with Polymedco, Inc. 2.Levin TR, Corley DA, Jensen CD, et al. Effects of organized colorectal cancer screening on cancer incidence and mortality in a large community-based population. Gastroenterology. 2018;155(5):1383-1391.e5. https://lnkd.in/dVsXZTcN